PRU=P2Y12 Reaction Units P2Y12 Platelet Reactivity is intended to measure the level of platelet P2Y12 receptor blockage resulting from P2Y12 receptor blocker drugs, such as clopidogrel and prasugrel. The PRU reference range in P2Y12 receptor blocker drug-naive population is 182-335, according to manufacturer's package insert. In general, PRU values lower than 180 are associated with expected antiplatelet effect. Factors that contribute to an inadequate response are drug interactions, underlying health conditions, non-compliance, and inherent platelet disorders. Drug response is also dependent on dosage and timing of testing. Patients taking P2Y12 inhibitors are at increased risk of perioperative bleeding due to platelet dysfunction from drug effect. It is recommended to discontinue use of P2Y12 drugs for 5-7 days prior to surgery to allow restoration of platelet function. PRU values greater than or equal to 180 are indication of no drug effect. This assay does not test aspirin drug response or platelet dysfunction unrelated to P2Y12 receptor blockage. Clinical decisions cannot be based solely upon this test result.